Friday, November 15, 2019

Warning: Significant numbers of patients take OTC products (particularly dietary supplements) with potentially serious interactions with the DOAC apixaban and appear to lack knowledge about potentially harmful interactions. Interventions are needed to educate patients and healthcare providers about potential dangers of taking interacting OTC products in combination with apixaban, and data are needed on outcomes associated with concomitant apixaban–OTC product use.

http://www.thedoctorwillseeyounow.com/content/stroke/art6007.html 
https://onlinelibrary.wiley.com/doi/abs/10.1111/jgs.16193

 
 

No comments: